تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
Citigroup Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $231.0B | |
|---|---|---|
| Revenue (ttm) | 83.3B | |
| Net income (ttm) | 17.9B | |
| EPS (ttm) | $10.2 | |
| Shares out | 1.7B | |
| P/E (trailing) | 12.2x | |
| P/E (forward) | 10.6x | |
| Dividend | $2.68 (2.16%) | |
| Volume | 4,504,854 | |
| Beta | 1.11 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $71.88B | $75.34B | $78.07B | $80.72B | $85.23B | +4.3% |
| Gross profit | $75.78B | $69.37B | $67.90B | $71.12B | $75.05B | -0.2% |
| Operating income | $27.47B | $18.81B | $12.91B | $17.05B | $19.83B | -7.8% |
| Net income | $21.95B | $14.85B | $9.23B | $12.68B | $14.31B | -10.2% |
| EPS (diluted) | $10.14 | $7.00 | $4.04 | $5.94 | $6.99 | -8.9% |
| EBITDA | $31.43B | $23.07B | $17.47B | $21.36B | $24.20B | -6.3% |
| R&D | — | — | — | — | $2.33B | — |
| SG&A | $25.25B | $26.75B | $29.32B | $28.63B | $29.73B | +4.2% |
Recent company headlines from major financial publishers.
The base path accepts the estimate-backed recovery but does not extend it indefinitely. It would weaken if post-FY2027 profitability fails to normalize or regional concentration rises materially.
Upside persists only if post-FY2027 earnings growth proves durable and the observed regional revenue breadth translates into steadier profit. Rising diluted shares or renewed margin weakness would disconfirm this path.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 7.2% | $103 | $104 | $105 | $106 | $108 |
| 8.2% | $92.2 | $92.2 | $92.2 | $92.1 | $92.0 |
| 9.2% | $83.9 | $83.5 | $82.9 | $82.2 | $81.4 |
| 10.2% | $77.3 | $76.5 | $75.7 | $74.7 | $73.6 |
| 11.2% | $71.7 | $70.8 | $69.9 | $68.8 | $67.5 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |